The Protecting Children from Experimentation Act of 2025 inserts a new section into chapter 110 of Title 18 to make it a federal crime for a health‑care professional to perform or aid gender‑transition procedures on a person under 18. The statute authorizes fines and up to five years’ imprisonment for covered professionals, and it creates a private civil cause of action for the person on whom a procedure was performed.
The bill matters because it federalizes regulation of gender‑affirming medical and surgical care for minors using a very broad interstate‑commerce hook, lists an extensive set of procedures (from puberty blockers to cosmetic facial surgery), and includes narrow medical exceptions while leaving open significant questions about enforcement, medical standards, and interaction with state law and health‑care practice norms.
At a Glance
What It Does
The bill adds 18 U.S.C. §2260B, which criminalizes a health‑care professional’s knowing performance or aiding of any ‘gender transition procedure’ on a minor and permits a civil suit by the treated person. Penalties include fines and up to five years’ imprisonment.
Who It Affects
Health‑care professionals and clinics that provide gender‑affirming hormonal or surgical care to patients under 18, telehealth platforms, suppliers and shippers of related medical products, and attorneys who represent affected individuals or providers.
Why It Matters
It attempts to shift regulation of minor‑age gender‑affirming care from state medical boards and legislatures to federal criminal law by relying on multiple interstate‑commerce predicates, potentially creating novel constitutional and implementation disputes and broad civil‑liability exposure for clinicians.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
Rather than working through medical licensing, reimbursement, or state tort law, this bill adds a federal criminal prohibition targeted at clinicians who provide gender‑transition services to anyone under 18. The criminal provision applies when the clinician ‘knowingly’ performs or aids the procedure and is keyed to a set of interstate‑commerce triggers — travel, use of telecommunications or mail, payments that affect commerce, or use of items that have moved across state lines.
The bill defines ‘gender transition procedure’ very broadly. It expressly covers puberty blockers, exogenous testosterone and estrogen at supraphysiologic doses, and a long list of surgeries from gonadectomy and mastectomy to facial feminization procedures, voice surgery, liposuction, implants, and what the bill describes as removal of otherwise healthy tissue.
It also carves out several exceptions, including treatment of medically verifiable disorders of sex development (DSDs), care for precocious puberty, and procedures necessary to treat physical illness or injury.On remedies, the statute bars criminal prosecution of the minor who receives the procedure but authorizes criminal penalties for the clinician and a civil action by the person on whom the procedure was performed. That civil remedy is permissive and would allow damages or “appropriate relief” against any person who performed the prohibited procedure.
The mix of criminal and civil enforcement tools, combined with the interstate‑commerce hooks, is designed to reach in‑person and remote care, out‑of‑state travel for care, and supply chains that cross state lines.Finally, the bill also includes explicit definitions of ‘male’, ‘female’, ‘sex’, and ‘minor’ tied to biological reproductive capacity and gives particular attention to excluding treatment for certain DSDs and standard pediatric indications such as precocious puberty. Those definitional choices and medical exclusions are likely to determine how courts, regulators, and clinicians interpret the scope of covered conduct and which clinical practices remain available for minors.
The Five Things You Need to Know
The bill creates 18 U.S.C. §2260B and makes it a federal crime for a health‑care professional to knowingly perform or aid a “gender transition procedure” on anyone under 18, punishable by fines and up to five years’ imprisonment.
The statute uses multiple interstate‑commerce predicates (travel, telecommunication, payments affecting commerce, items that crossed state lines) so that in‑state care connected to any of those activities could trigger federal jurisdiction.
The definition of “gender transition procedure” is expansive and lists specific drugs (GnRH agonists, testosterone, estrogen at supraphysiologic doses) and a long catalog of surgeries and aesthetic procedures, including facial feminization, implants, liposuction, mastectomy, and removal of otherwise healthy tissue.
The bill expressly exempts treatment for medically verifiable disorders of sex development (DSDs), prescriptions for precocious puberty, male circumcision, and emergency or medically necessary procedures addressing physical illnesses or injuries.
No minor may be arrested or prosecuted under the statute, but the person on whom a procedure is performed can bring a civil suit against each person who performed the procedure, creating parallel criminal and private enforcement pathways.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Sets the Act’s short title as the “Protecting Children from Experimentation Act of 2025.” This part is purely captioning and has no operational effect on scope or enforcement.
Federal crime for performing or aiding gender‑transition procedures on minors
Adds a criminal prohibition that applies to any ‘physical or mental health care professional’ who knowingly performs or aids and abets a gender transition procedure on a minor. The maximum sentence is five years’ imprisonment and a fine under Title 18. Practical consequences include potential disbarment from Medicare/Medicaid participation and professional‑licensing investigations triggered by federal criminal referrals.
No criminal exposure for minors; private civil actions by treated persons
Section 2(b) shields minors from arrest or prosecution under the new section. Section 2(c) creates a private right of action allowing the person on whom a procedure was performed to sue each person who performed it for ‘appropriate relief.’ That opens a civil channel for damages, injunctions, or other judicial remedies even where prosecutors decline to indict, and it raises issues about who may sue on behalf of a minor and when (statute‑of‑limitations questions are not addressed in the text).
Broad jurisdictional hooks to federalize prosecutions
The bill specifies seven circumstances that establish federal jurisdiction: travel in interstate or foreign commerce; use of channels or instrumentalities of commerce (including telehealth); payments affecting commerce; transmission of communications in commerce; use of instruments or items that moved across state lines; conduct in U.S. special maritime or territorial jurisdiction; or any conduct that otherwise occurred in or affected interstate or foreign commerce. Those enumerated predicates are intentionally broad and are meant to cover in‑person out‑of‑state care, telemedicine, shipped medical supplies and implants, and typical financial transactions.
Detailed definitions of ‘gender transition procedure,’ ‘male/female/sex,’ and medical exceptions
Contains a series of operative definitions: ‘minor’ (under 18); sex (male or female defined by reproductive function); and an exhaustive list of covered procedures under ‘gender transition procedure.’ The definition includes both hormonal regimens at supraphysiologic doses and a wide range of surgical and cosmetic procedures. It also lists exclusions: treatment for DSDs with medical verification, treatment of precocious puberty, male circumcision, and medically necessary procedures for physical illness or injury. The breadth of the list coupled with narrowly specified medical exceptions makes the definitional section determinative of enforcement scope.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Parents and guardians who oppose gender‑affirming care: the statute gives them federal criminal law backing and a private civil pathway to challenge procedures performed on minors, effectively providing a federal enforcement lever that some states or parents may have lacked.
- Minors who, under the bill’s sponsors’ premise, would be protected from irreversible medical or surgical interventions until adulthood; the private‑right‑of‑action also enables individuals to seek damages or other judicial relief later in life.
- Plaintiff attorneys and advocacy organizations that litigate on behalf of individuals who received procedures as minors: the statute supplies a statutory cause of action and clear list of covered procedures that can support civil litigation strategies.
Who Bears the Cost
- Health‑care professionals and clinics that provide gender‑affirming care to minors: they face criminal exposure, potential imprisonment, fines, and civil liability, which will likely increase malpractice and liability insurance costs and could chill provision of care.
- Telehealth platforms, pharmacies, and medical suppliers: because the bill’s jurisdictional triggers cover telemedicine, mail, shipments, and payments, these intermediaries may need compliance programs, enhanced screening, or may decline to serve patients seeking care for gender‑related conditions.
- State and local governments and medical boards in jurisdictions that authorize or regulate gender‑affirming care: they may incur litigation and defense costs, face conflicts between state licensing rules and federal criminal law, and see hospitals adjust services to avoid federal exposure.
Key Issues
The Core Tension
The central tension is between a federal desire to prevent irreversible medical and surgical interventions for minors and the competing interests of medical autonomy, parental decision‑making, and state control over health‑care regulation; the bill solves for nationwide prohibition by criminalizing clinician conduct tied to commerce, but in doing so it substitutes federal criminal law for clinical judgment and state regulatory regimes, creating trade‑offs between uniform protection and local medical standards.
The bill’s most significant practical puzzles arise from its jurisdictional design and sweeping definitions. By design, the interstate‑commerce predicates sweep in common clinical activities — telehealth visits, pharmacies filling prescriptions across state lines, travel for care, and the shipment of implants — which makes the statute effective nationwide but also invites constitutional challenges under the Commerce Clause and questions about federalism.
Courts will have to decide whether Congress may criminalize a wide swath of in‑state medical practice when tied to ordinary commercial channels.
The definitional choices raise medical and interpretive problems. Terms like ‘supraphysiologic’ lack a precise statutory benchmark and could require courts to endorse particular clinical thresholds or expert testimony to determine whether a dose is covered.
The statute’s long laundry list of surgical and aesthetic procedures — including routine cosmetic interventions such as liposuction or implants when performed ‘to feminize or masculinize’ — creates ambiguity about surgeon intent and patient motive, and it risks ensnaring common pediatric procedures depending on their stated purpose. The DSD exclusions rely on ‘medically verifiable’ diagnoses and genetic or biochemical testing; however, the text does not establish who certifies verifiability or the evidentiary standard in civil and criminal proceedings.
Implementation also raises enforcement and practical questions the bill leaves unanswered: how prosecutors should allocate resources against clinicians, whether insurers must refuse reimbursement or simply decline to cover procedures for minors, who can bring civil suits on behalf of minors (parents or guardians, or the minor upon reaching majority), and how courts will treat retroactive claims for procedures performed before enactment. The combination of criminal penalties and private suits, plus the broad interstate hooks, ensures high‑stakes litigation that will test the boundaries of medical practice regulation and federal authority.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.